TAMARA PLATNER: Open Payments
NPI 1518156827 · OWOSSO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 41 payments from 20 companies in 2025. Trend: 2023 $184 · 2024 $343 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $138 |
| Biogen, Inc. | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $52 |
| PFIZER INC. | 2 | $43 |
| Averitas Pharma Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $31 |
| Eisai Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $25 |
Products named: QULIPTA, TYSABRI, HYQVIA, QUTENZA, AMYVID, Leqembi, INGREZZA, PONVORY.
Industry payments across MI — which companies pay providers there.
